Woo J - Search Results

1

Multiplexed PLGA scaffolds with nitric oxide-releasing zinc oxide and melatonin-modulated extracellular vesicles for severe chronic kidney disease.

Rhim WK, Woo J, Kim JY, Lee EH, Cha SG, Kim DS, Baek SW, Park CG, Kim BS, Kwon TG, Han DK. Rhim WK, et al. Among authors: woo j. J Adv Res. 2024 Mar 25:S2090-1232(24)00118-8. doi: 10.1016/j.jare.2024.03.018. Online ahead of print. J Adv Res. 2024. PMID: 38537702 Free article.

2

Comparison of Surface Functionalization of PLGA Composite to Immobilize Extracellular Vesicles.

Woo J, Ko KW, Cha SG, Heo Y, Han DK. Woo J, et al. Polymers (Basel). 2021 Oct 22;13(21):3643. doi: 10.3390/polym13213643. Polymers (Basel). 2021. PMID: 34771200 Free PMC article.

3

Bolstering the secretion and bioactivities of umbilical cord MSC-derived extracellular vesicles with 3D culture and priming in chemically defined media.

Kim JY, Rhim WK, Cha SG, Woo J, Lee JY, Park CG, Han DK. Kim JY, et al. Among authors: woo j. Nano Converg. 2022 Dec 19;9(1):57. doi: 10.1186/s40580-022-00349-z. Nano Converg. 2022. PMID: 36534191 Free PMC article.

4

Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer.

Woo JW, Han EK, Suh KJ, Kim SH, Kim JH, Park SY. Woo JW, et al. Breast Cancer Res Treat. 2024 Sep;207(2):301-311. doi: 10.1007/s10549-024-07359-x. Epub 2024 May 16. Breast Cancer Res Treat. 2024. PMID: 38753066 Free PMC article.

5

Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast.

Kim M, Chung YR, Kim HJ, Woo JW, Ahn S, Park SY. Kim M, et al. Breast Cancer Res. 2020 Mar 26;22(1):32. doi: 10.1186/s13058-020-01267-w. Breast Cancer Res. 2020. PMID: 32216826 Free PMC article.

6

Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer.

Ahn S, Chung YR, Seo AN, Kim M, Woo JW, Park SY. Ahn S, et al. PLoS One. 2020 May 13;15(5):e0233037. doi: 10.1371/journal.pone.0233037. eCollection 2020. PLoS One. 2020. PMID: 32401825 Free PMC article.

7

PD-L1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance.

Han EK, Woo JW, Suh KJ, Kim SH, Kim JH, Park SY. Han EK, et al. Cancer Res Treat. 2024 Apr;56(2):557-566. doi: 10.4143/crt.2023.1025. Epub 2023 Dec 12. Cancer Res Treat. 2024. PMID: 38097920 Free PMC article. Review.

8

Correction to: miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast.

Woo JW, Choi HY, Kim M, Chung YR, Park SY. Woo JW, et al. Breast Cancer. 2023 Jan;30(1):156. doi: 10.1007/s12282-022-01412-7. Breast Cancer. 2023. PMID: 36334184 No abstract available.

9

Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer.

Han SH, Kim M, Chung YR, Woo JW, Choi HY, Park SY. Han SH, et al. Sci Rep. 2022 Nov 27;12(1):20367. doi: 10.1038/s41598-022-24890-3. Sci Rep. 2022. PMID: 36437379 Free PMC article.

10

Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status.

Bai K, Woo JW, Kwon HJ, Chung YR, Suh KJ, Kim SH, Kim JH, Park SY. Bai K, et al. Lab Invest. 2024 Aug;104(8):102092. doi: 10.1016/j.labinv.2024.102092. Epub 2024 Jun 8. Lab Invest. 2024. PMID: 38857783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,098 results

Search Page

Filters